Oliver Lagore Vanvalin Investment Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115 | Buy |
+8
| New | +$115 | ﹤0.01% | 635 |
|
|
2024
Q4 | $127 | Hold |
8
| – | – | ﹤0.01% | 661 |
|
|
2024
Q3 | $192 | Hold |
8
| – | – | ﹤0.01% | 649 |
|
|
2024
Q2 | $159 | Sell |
8
-23
| -74% | -$457 | ﹤0.01% | 697 |
|
|
2024
Q1 | $617 | Buy |
31
+23
| +288% | +$458 | ﹤0.01% | 659 |
|
|
2023
Q4 | $179 | Hold |
8
| – | – | ﹤0.01% | 712 |
|
|
2023
Q3 | $162 | Hold |
8
| – | – | ﹤0.01% | 791 |
|
|
2023
Q2 | $204 | Hold |
8
| – | – | ﹤0.01% | 746 |
|
|
2023
Q1 | $238 | Hold |
8
| – | – | ﹤0.01% | 670 |
|
|
2022
Q4 | $216 | Hold |
8
| – | – | ﹤0.01% | 634 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 636 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 615 |
|
|
2022
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 562 |
|